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Bloodstream Infection
When Is Transthoracic Echocardiography Sufﬁcient?*Achim J. Kaasch, MD,y Guido Michels, MDzI n our hospital, patients with Staphylococcusaureus bloodstream infection (SAB) are all seenby an infectious diseases physician. Recently,
the following conversation took place on the cardio-
logy ward:
“This patient needs a transesophageal echocardi-
ography [TEE] right away,” claimed the infectious
diseases physician.
“No way, our guidelines say that this patient
needs transthoracic echocardiography [TTE] ﬁrst, and
possibly TEE later,” replied the cardiologist.
The physician on call stepped in: “This patient has
a proven catheter-related SAB and no risk factors for
infective endocarditis; do we really need echocardi-
ography at all?”
The debate went on for a while; time for us to
quickly review the facts.
Infective endocarditis (IE) caused by Staphylo-
coccus aureus is associated with an increased risk of
embolic events and high morbidity and mortality
(1). It frequently occurs in patients with SAB, with
rates commonly reported from 5% to 15% in unbiased
cohort studies. The role of echocardiography in pa-
tients with SAB should not be underestimated. As a
major Duke criterion, it helps to diagnose IE, which
can be either the cause or consequence of SAB. The
results of echocardiography are crucial to determine
further interventions, such as heart surgery or pace-
maker removal, as well as the necessary duration of
antibiotic treatment.*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the yInstitute for Medical Microbiology, Immunology and Hygiene,
University of Cologne, Cologne, Germany; and the zDepartment III of
Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Dr. Kaasch has received lecture honoraria from BD Biosciences,
Biomérieux, MSD Sharp and Dohme, and ViiV Healthcare; and travel
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from Novartis and Berlin-Chemie AG.Thus, it is no surprise that guidelines endorse
routine echocardiography in all patients with SAB
(2–4); however, the consensus ends when it comes to
the technique of imaging. TEE is deemed superior to
TTE in detecting small vegetations, perforations, and
periannular abscesses and in diagnosing IE that in-
volves prosthetic valves or intracardiac device leads.
Therefore, the Infectious Disease Society of America
(IDSA) recommends performing TEE (2), an approach
that is endorsed by many physicians.
The current guidelines of the American College of
Cardiology/American Heart Association (ACC/AHA)
and the European Society of Cardiology (ESC) focus on
patients with a risk of IE or with suspected IE. They
recommendTTE as the initial technique of choice (3,4).
Whereas the ACC/AHA states that TEE may be consid-
ered in most cases with SAB, the ESC recommends
proceeding to TEE in case of negative TTE with high
clinical suspicion of IE, suboptimal TTE quality, pres-
ence of prosthetic valves or intracardiac device leads,
positive TTE, and congenital heart defects.
The indiscriminate use of TEE in all patients with
SAB has been criticized for a number of reasons. First,
TEE is a semi-invasive technique and usually requires
sedation. Although severe complications are rare, the
incidence of respiratory complications in patients with
sedation is not negligible (5). Second, when the clinical
suspicion of IE is low and image quality in TTE is good,
an additional TEEmay not be necessary (3). Third, TEE
is more resource intensive and thus more costly than
TTE and may not always be available. As a result,
compliance with the IDSA recommendation to perform
TEE in patients with SAB varies extensively between
observational studies (rate of TEE 15% to 80% [6]).
With this in mind, a clinical risk stratiﬁcation to
guide the use of TEE seems sensible, and several stra-
tegies have been proposed (7–9). Risk factors for IE
in SAB that have been assessed in these studies in-
clude community acquisition, presence of a prosthetic
heart valve or intracardiac device, positive follow-up
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933blood cultures, hemodialysis dependence, presence of
secondary foci of infection, and clinical signs of IE.
In this issue of iJACC, Showler et al. (10) present
criteria that predict when TTE examination is sufﬁ-
cient to exclude IE in patients with SAB. They report
data from a retrospective cohort study on 833 adult
patients with SAB who were admitted to 7 hospitals
over a 3-year period. From a randomly chosen subset
of 268 patients who had received TTE, they derived
4 high-risk criteria that predicted IE by logistic
regression. Positive TTE, community acquisition,
intravenous drug use, and high-risk cardiac condi-
tion (presence of foreign material, congenital heart
disease, cardiac transplantation with valvulopathy,
and history of IE) were identiﬁed as criteria. In a
similarly sized cohort, these criteria were validated
to guard against overﬁtting of the underlying sta-
tistical model. The authors show that with these
criteria, a population of low-risk patients can be
identiﬁed with high precision in whom TTE is suf-
ﬁcient to exclude the diagnosis of IE.SEE PAGE 924The study is remarkable for 2 reasons. First, the
criteria are easy to apply, and second, many patients
are classiﬁed as at low risk for IE. Thus, in a large
proportion of patients (45%), further advancing to
TEE would not be necessary. Interestingly, clinical
factors (such as persistent fever or septic embolic
events) and positive follow-up blood cultures were
not represented in the score, which considerably fa-
cilitates its use. Nevertheless, many studies have
highlighted the importance of follow-up blood cul-
tures in predicting IE and other complications of SAB.In the study by Showler et al. (10), follow-up blood
cultures were performed in just 47% of cases and may
therefore not have emerged in the statistical analysis
as a predictor of IE.
The study has several limitations that may have led
to underdetection of IE. Foremost, its retrospective
design warrants caution. The diagnosis of IE could
have been missed in some patients because of insuf-
ﬁcient documentation or missing follow-up informa-
tion. Furthermore, the low rate of TEE (14%), the
timing of echocardiography, and a prolonged course
of antibiotic drug treatment could have masked IE in
patients with small lesions at the time of TTE. These
limitations should be addressed in future prospective
studies that ideally will integrate a multidisciplinary
team in the diagnosis and management of IE (11).
The strategy presented by Showler et al. (10) will
not end the debate on when to perform TEE, and it
has not addressed whether some patients with SAB
do not need echocardiography at all. However, it is
an important step towards a scientiﬁcally justiﬁed
imaging algorithm. Such an algorithm needs to be
based on a common consensus of cardiologists, in-
fectious disease physicians, and clinical microbiolo-
gists. It should take into account differing views and
would then markedly improve patient management
and end bedside discussion on whose guidelines are
more appropriate.
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